San Gabriel Clinical Reserach LLC is categorized under Medical Labs in Georgetown, TX and active since 2010.
San Gabriel Clinical Reserach LLC was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Gregory Willis at the company’s single location by writing to 3201 South Austin Avenue, Georgetown, Texas TX 78626 or by phoning (609) 393-8151. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | San Gabriel Clinical Reserach LLC |
| Contact Person: | Gregory Willis |
| Address: | 3201 South Austin Avenue, Georgetown, Texas 78626 |
| Phone Number: | (609) 393-8151 |
| Website Address: | gtownplaza.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
San Gabriel Clinical Reserach LLC was started in 2010 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Gregory Willis for inquiries that concern San Gabriel Clinical Reserach LLC by calling the company number (609) 393-8151, as your correspondence is most welcome. Additionally, the physical location of the single location of San Gabriel Clinical Reserach LLC can be found at the coordinates as well as the street address 3201 South Austin Avenue in Georgetown, Texas 78626.
For its online presence, you may visit San Gabriel Clinical Reserach LLC’s website at gtownplaza.com and engage with its social media outlets through on Twitter and on Facebook.